Feature

U.S. and African programs aim to improve understanding, treatment of sickle cell disease


 

SCDIC

Cheryl Anne Boyce, PhD, chief of the Implementation Science Branch at the Center for Translation Research and Implementation Science at NHLBI, discussed the United States–based Sickle Cell Disease Implementation Consortium (SCDIC).

“The goals of the consortium are to develop a registry in collaboration with other centers and the NHLBI, as well as a needs-based community assessment of the barriers to care for subjects with sickle cell disease,” Dr. Boyce said. “We also wanted to design implementation research studies that address the identified barriers to care.”

Dr. Boyce said the SCDIC’s registry is open to patients aged 15-45 years who have a confirmed SCD diagnosis, speak English, and are able to consent to and complete a survey. The registry has enrolled almost 2,400 patients from eight centers over 18 months.

The SCDIC has also performed a needs assessment that prompted the development of three implementation research studies. The first study involves using mobile health interventions to, ideally, increase patient adherence to hydroxyurea and improve provider knowledge of hydroxyurea.

With the second study, researchers aim to improve the care of SCD patients in the emergency department by using an inpatient portal. The goals of the third study are to establish a standard definition for unaffiliated patients, conduct a needs assessment for this group, and develop an intervention that can provide these patients with guideline-based SCD care.


Get Connected

Kim Smith-Whitley, MD, director of the Comprehensive Sickle Cell Center at the Children’s Hospital of Philadelphia and a board member of the Sickle Cell Disease Association of America (SCDAA), described Get Connected, “an information-sharing network and patient-powered registry” created by SCDAA.

Dr. Smith-Whitley said one purpose of Get Connected is to provide a network that facilitates “the distribution of information related to clinical care, research, health services, health policy, and advocacy.”

The network is open to families living with SCD and sickle cell trait, SCDAA member organizations, health care providers, clinical researchers, and community-based organizations.

Get Connected also includes a registry for SCD patients that stores information on their diagnosis and treatment, as well as online communities that can be used to share information and provide psychosocial support.

Thus far, Get Connected has enrolled 6,329 individuals. This includes 5,100 children and adults with SCD, 652 children and adults with sickle cell trait, and 577 nonpatients.

The webinar presenters did not disclose any conflicts of interest.

Pages

Recommended Reading

Femoral head decompression relieves SCD hip pain
MDedge Hematology and Oncology
Study: Why urban sickle cell patients quit hydroxyurea
MDedge Hematology and Oncology
Crizanlizumab shows posttreatment effect in sickle cell
MDedge Hematology and Oncology
Noninvasive prenatal test may detect sickle cell disease
MDedge Hematology and Oncology
Sickle cell unit running 24/7 reduces readmissions, emergency visits
MDedge Hematology and Oncology
Hemoglobin levels are associated with long-term dementia risk
MDedge Hematology and Oncology
Timing, volume of transfusion may not matter in children with severe anemia
MDedge Hematology and Oncology
Two iron chelators better than one for thalassemia major
MDedge Hematology and Oncology
Quercetin may reduce iron overload in beta-thalassemia major
MDedge Hematology and Oncology
Mitapivat elicits positive response in pyruvate kinase deficiency
MDedge Hematology and Oncology